semaglutide ema approval Novo's Wegovy Pill Receives as First Oral Weight-Loss Treatment in Europe, ETPharma EMA safety committee to review

Its about looking after your health, sticking to your treatment goals, and keeping your weight under control in the long run

Science 360 , eaap7847 (2018)

Nave (non-infected) erythrocytes and Plasmodium falciparum 3D7-infected erythrocytes were cultured at 37C, in low oxygen conditions (1% O 2 , 5% CO 2 , 94% N 2 ), at 4% or 0.4% hematocrit, in incomplete RPMI media (iRPMI: RPMI 1640 HEPES, 50 mg/L hypoxanthine, 10 mg/L gentamicin, pH 6.74), complete RPMI media (cRPMI: incomplete RPMI supplemented with 2.25 g/L sodium bicarbonate and 5 g/L AlbuMAX II), or Ringer solution (1mM CaCl 2 , 5mM glucose, 32 mM HEPES pH 7.4, 5 mM KCl, 1mM MgSO4, 125mM NaCl)

Protect neurons in patients with Parkinsons disease

Valenton, board certified doctor and Lemme Medical Advisory Board Member

Pancreas GLP-1 and GIP stimulate insulin secretion GLP-1 suppresses glucagon secretion during hyperglycemia GIP suppresses glucagon secretion during hyperglycemia and stimulates secretion during euglycemia and hypoglycemia Brain GLP-1 and GIP suppress hunger Stomach GLP-1 slows gastric emptying Fat tissue GIP increases fatty acid and glucose uptake by fat tissue [1,2,3] Tirzepatide Tirzepatide is a dual GLP-1 / GIP receptor agonist that mimics the actions of GLP-1 and GIP